[go: up one dir, main page]

AU2001290636A1 - Method for reducing toxicity of combined chemotherapies - Google Patents

Method for reducing toxicity of combined chemotherapies

Info

Publication number
AU2001290636A1
AU2001290636A1 AU2001290636A AU9063601A AU2001290636A1 AU 2001290636 A1 AU2001290636 A1 AU 2001290636A1 AU 2001290636 A AU2001290636 A AU 2001290636A AU 9063601 A AU9063601 A AU 9063601A AU 2001290636 A1 AU2001290636 A1 AU 2001290636A1
Authority
AU
Australia
Prior art keywords
reducing toxicity
combined chemotherapies
chemotherapies
combined
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290636A
Other languages
English (en)
Inventor
Luca Gianni
Giorgio Minotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2001290636A1 publication Critical patent/AU2001290636A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001290636A 2000-09-22 2001-09-06 Method for reducing toxicity of combined chemotherapies Abandoned AU2001290636A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23470800P 2000-09-22 2000-09-22
US60/234,708 2000-09-22
PCT/US2001/027612 WO2002024178A2 (fr) 2000-09-22 2001-09-06 Procede de reduction de chimiotherapies combinees

Publications (1)

Publication Number Publication Date
AU2001290636A1 true AU2001290636A1 (en) 2002-04-02

Family

ID=22882468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290636A Abandoned AU2001290636A1 (en) 2000-09-22 2001-09-06 Method for reducing toxicity of combined chemotherapies

Country Status (3)

Country Link
US (1) US20020049169A1 (fr)
AU (1) AU2001290636A1 (fr)
WO (1) WO2002024178A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003222A (es) * 2003-09-25 2006-05-22 Astellas Pharma Inc Agente antitumoral que comprende un inhibidor de histona desacetilasa y un inhibidor de topoisomerasa ii.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333905T2 (de) * 1992-12-23 2006-08-03 Bristol-Myers Squibb Co. Seitenkette tragende Taxane und deren Zwischenprodukte
CA2111527C (fr) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethylethers de derives du taxane
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
WO2002024178A2 (fr) 2002-03-28
WO2002024178A3 (fr) 2003-03-13
US20020049169A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001260368A1 (en) Implementation method of pilot signal
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2002363005A1 (en) Derivatives of uk-2a
AU6397301A (en) Synchronization method
AU2651701A (en) Method for introducing additives
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001249981A1 (en) Method of payroll access
AU2001237355A1 (en) Method for making an oxirane
AU2001270307A1 (en) Method of making teprenone
AU2001238696A1 (en) Method of reducing defects
AU2001288831A1 (en) Method of compensating flare-induced cd changes
AU6381701A (en) Bisamidino compounds as nhe-3 inhibitors
AU2002223548A1 (en) Improved method for the biosynthesis of vitamin e
AU2001294258A1 (en) Method of purifying plavastatin
AU2001288092A1 (en) Method of crystallization
AU2001284039A1 (en) Chromanone derivatives
AU2001248316A1 (en) Method for making an oxirane
AU2002214487A1 (en) Method for inducing apoptiosis
AU2002216479A1 (en) Isolation method
AU2001213451A1 (en) Method for preparation of polycarbonates
PL366100A1 (en) Method for reducing toxicity of combined chemotherapies
AU2002214883A1 (en) Isolation of taxanes
AU2001227697A1 (en) Method for purification of acetone
AU2003296451A1 (en) Method of reducing toxicity of anticancer agents
AU2001290636A1 (en) Method for reducing toxicity of combined chemotherapies